Upstream Bio (UPB) Invested Capital (2023 - 2025)
Historic Invested Capital for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $378.6 million.
- Upstream Bio's Invested Capital rose 33615.6% to $378.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $378.6 million, marking a year-over-year increase of 33615.6%. This contributed to the annual value of $469.9 million for FY2024, which is 48160.26% up from last year.
- According to the latest figures from Q3 2025, Upstream Bio's Invested Capital is $378.6 million, which was up 33615.6% from $408.7 million recorded in Q2 2025.
- In the past 5 years, Upstream Bio's Invested Capital registered a high of $469.9 million during Q4 2024, and its lowest value of -$160.3 million during Q3 2024.
- For the 3-year period, Upstream Bio's Invested Capital averaged around $114.1 million, with its median value being -$112.2 million (2023).
- Examining YoY changes over the last 5 years, Upstream Bio's Invested Capital showed a top increase of 48160.26% in 2024 and a maximum decrease of 4287.46% in 2024.
- Over the past 3 years, Upstream Bio's Invested Capital (Quarter) stood at -$123.1 million in 2023, then soared by 481.6% to $469.9 million in 2024, then fell by 19.42% to $378.6 million in 2025.
- Its Invested Capital was $378.6 million in Q3 2025, compared to $408.7 million in Q2 2025 and $445.6 million in Q1 2025.